Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • yul
    Junior Member
    • May 2015
    • 1

    How do I know whether my fastq file is ready for alignment?

    I received my fastq files from a ChIP-Seq experiment. The Sequencing core guy told me that the raw data was converted from .bcl file format to .fastq format using CASAVA v1.8.2. They run a standard paired-end sequencing reaction to generate 50 bp of sequence in each direction in the Illumina HiSeq2000 platform.
    How do I know whether the fastq files are ready for alignment to generate the bam files using Bowtie? This is because I wonder how to know in the fastq file that the adaptors/barcodes have been removed from the read. If the fastq files still contain these primers how do I know it and how do I trim them.
    Below and attaching a couple of reads from the fastq files:
    @D5VG2KN1:206:C3LG1ACXX:8:1101:1216:2098 1:N:0:GCCAAT
    CTTGACAAGCGCTTTCTTCAGAGTGCCCTCGCTCGTCCTATCTACAAAGCT
    +
    CCCFFFFFHHHHHJJIJJJJJJJFHIJJJJJJIJDHIJJIJIJJJJJJJJJ
    @D5VG2KN1:206:C3LG1ACXX:8:1101:1437:2084 1:N:0:GCCAAT
    TTTACCTTGTGTTAATTTTATTCAAAGCCAGAAACAATATGCATCCGGTTG
    +
    CCCFFFFFHHHHHJIIJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJHJJ

    this is kind of basic but and I a newbie in NGS analysis.
    thanks for any clues
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    The easiest way is to trim adapters and see if anything happens. The tool will report whether or not there were adapters.

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      Your file is ready for alignment now but it is always a good idea to pass it through a trimming program to remove any extraneous sequence (adapters etc) that may be present.

      Comment

      • TonyBrooks
        Senior Member
        • Jun 2009
        • 303

        #4
        FastQC (http://www.bioinformatics.babraham.a...ojects/fastqc/) has a module that checks for adapter contamination. It looks for the universal adapter sequences (used in TruSeq RNA/DNA and NEBNext among others), the Nextera sequences and Illumina small RNA sequences.
        It looks for both read-through and dimer (over-represented sequences).

        In general, it's always a good idea to run your fastq through FastQC to check it looks as expected. HOWEVER, please be aware that the tests implemented assume you are sequencing highly diverse, genomic material. You may get failed modules on perfectly good data as the assumptions made when performing the test are incorrect. Check the documentation and ask yourself "Is this test applicable to my data set"? For example, you may see a high level of duplication when sequencing highly enriched samples (such as ChIP and/or RNA-Seq).

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 11:41 AM
        0 responses
        8 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        34 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        44 views
        0 reactions
        Last Post SEQadmin2  
        Working...